What does FDA trials and approvals in the U.S. have to do with the Philippines? If this is all you can provide for a link that says CytoDyn cannot sell Leronlimab under CSP then you've provided proof there is no link.
You are aware of what "to date" means? in this case it simply means the end date of the time period covered in the 10Q.
None of that matters. It is a pre-rev bio-tech in trials. Now broadening it's horizons in other countries. The Philippines will turn into revenue very shortly.
It is my opinion the "NO REVENUES to date" will be changing very shortly. Once the sales begin in the Philippines based on Estrada and the other 25 CSP cases, other countries will also be jumping on board if not already. The bonus is: The FDA and hopefully Fauci may have to answer some serious questions if a US made drug is saving people in other countries but not here in the US.
Anyway. in my opinion, things they are a changing and things are looking up.